Prevention of Contraceptive Failures with Hormonal Implants
Hormonal implants have been in the process of research and development for the last 17 years. Up to the present time the only model which has become a finished product is the NORPLANT(R)* implant system, manufactured by Leiras Pharmaceuticals from Finland under license from the Population Council of New York. A few other models, such as CAPRONOR(R) and a second NORPLANT implant system, are well advanced in the development process.
KeywordsFamily Planning Unwanted Pregnancy Cervical Mucus Contraceptive Failure Population Council
Unable to display preview. Download preview PDF.
- Bonnar, J., McNicol, G. P., Douglas, A. S. Blood coagulation and fibrinolysis. In Ronald R. Macdonald, ed., Scientific Basis of Obstetrics and Gynaecology. J & A Churchill, London, p. 207, 1971.Google Scholar
- Requena, M. The problem of induced abortion in Latin America. Demography (2):785, 1968.Google Scholar
- The International Committee for Contraception Research of The Population Council. Contraception with long-acting subdermal implants: I. An effective and acceptable modality in international clinical trials. Contraception 18(4):315, 1978.Google Scholar